Palvella Therapeutics (PVLA) Enterprise Value Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Palvella Therapeutics | 1.47 Bn | 1.21 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -75.58% |
| Dec 31, 2025 | 0.67% |
| Sep 30, 2025 | 3.08% |
| Jun 30, 2025 | 4.53% |
| Mar 31, 2025 | 8.97% |
| Dec 31, 2024 | 10.79% |
| Sep 30, 2024 | 25.89% |
| Jun 30, 2024 | 45.90% |
| Mar 31, 2024 | 54.61% |
| Dec 31, 2023 | 38.58% |
| Sep 30, 2023 | 11.79% |
| Jun 30, 2023 | 5.66% |
| Mar 31, 2023 | 17.69% |
| Dec 31, 2022 | 17.18% |
| Sep 30, 2022 | 6.80% |
| Jun 30, 2022 | 6.71% |
| Mar 31, 2022 | 3.27% |
| Dec 31, 2021 | 2.02% |
| Sep 30, 2021 | 36.65% |
| Jun 30, 2021 | 15.28% |
| Mar 31, 2021 | 25.18% |
| Dec 31, 2020 | 1.02% |
| Sep 30, 2020 | 2.78% |
| Jun 30, 2020 | -15.34% |
| Mar 31, 2020 | -16.24% |
| Dec 31, 2019 | -52.52% |
| Sep 30, 2019 | -33.12% |
| Jun 30, 2019 | -35.16% |
| Mar 31, 2019 | -52.58% |
| Dec 31, 2018 | -62.17% |
| Sep 30, 2018 | -62.07% |
| Jun 30, 2018 | -146.93% |
| Mar 31, 2018 | -129.70% |
| Dec 31, 2017 | -57.83% |
| Sep 30, 2017 | -357.97% |
| Jun 30, 2017 | -223.61% |
| Mar 31, 2017 | -156.59% |
| Dec 31, 2016 | -99.64% |
| Sep 30, 2016 | -3,659.50% |
| Jun 30, 2016 | -1,880.16% |